Global Open Air Merchandisers and Accessories Market Gears Up for USD 3,385.9 Million Valuation Upto 2033, Driving 6.4% CAGR Growth

The open air merchandisers and accessories market is poised for rapid expansion, with a projected valuation of USD 1,813.6 million in 2023. Demonstrating a robust Compound Annual Growth Rate (CAGR) of 6.4% from 2023 to 2033, as reported by Future Market Insights, the market is expected to exceed a noteworthy valuation of USD 3,385.9 million by the end of the forecast period in 2033.

A key driver fueling this remarkable growth is the escalating demand for high-capacity devices designed to meet specialized storage needs. Notably, the healthcare sector, including hospitals and clinics, has emerged as a significant contributor to this heightened demand. These establishments require efficient and reliable solutions for storing medications and medical equipment, necessitating specific storage conditions such as temperature and humidity control. Open air merchandisers and accessories offer practical and cost-effective means to fulfill these stringent storage requirements. This market trajectory underscores its strategic importance in meeting the evolving needs of critical sectors and signifies its pivotal role in providing efficient storage solutions.

Start Exploring Now – Request Your Free Sample Report. https://www.futuremarketinsights.com/reports/sample/rep-gb-17116

Key Insights from the Market Analysis:

  • The global open air merchandizers and accessories market witnessed a steady growth with a Compound Annual Growth Rate (CAGR) of 5.5% from 2018 to 2022.
  • In 2022, North America emerged as the dominant region in the global open-air merchandizers and accessories market, contributing to more than 23.7% of the total revenue share.
  • Within North America, the United States (U.S.) market for open-air merchandizers and accessories is projected to demonstrate a 5.4% year-on-year growth by volume.
  • The United Kingdom is poised to lead the Western Europe market, with a forecasted Compound Annual Growth Rate (CAGR) of 6.1% over the designated period.

Further Valuable Insights Provided:

Future Market Insights presents an impartial analysis of the global open air merchandizers and accessories market, encompassing historical data spanning from 2018 to 2022 and forecasted statistics extending from 2023 to 2033.

To discern opportunities within the open air merchandizers and accessories market, the report is categorized based on installation type (counter mounted, drop in, freestanding, and under counter), refrigeration type (remote refrigeration and self-contained refrigeration), components (evaporator, compressor, condenser, thermostat, and capillary tube), and distribution channel (offline stores and online retail stores), covering five significant regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

Competitive Landscape:

Prominent players in the global market include:

Beverage-Air, Koolmore, Koldline, Delfield, Hyrda Kool, Marchia, Kool-It, Avantco Refrigeration, Micro Market, Universal.

Noteworthy Developments from Key Players:

In March 2023, Accucold, a division of Felix Storch, Inc. (FSI), expanded its range of vaccine refrigeration equipment certified to the NSF/ANSI 456 Vaccine Storage Standard. The Accucold Pharma-Vac Performance Series, available in 9 sizes, adheres to the latest standard through testing by an ANSI-accredited third-party laboratory.

In January 2023, Traulsen introduced its TF Flex Drawer under-counter refrigerator/freezer, equipped with a unique feature allowing the temperature of each drawer to be adjusted from cooling to freezing with a simple touch. Each drawer has the flexibility to operate at distinct temperature settings.

Access Exclusive Content – Secure The Premium Report Now! https://www.futuremarketinsights.com/checkout/17116

Key Segments Profiled in the Open Air Merchandizers and Accessories Market:

By Installation Type:

  • Counter Mounted
  • Drop In
  • Freestanding
  • Under Counter

By Refrigeration Type:

  • Remote Refrigeration
  • Self-contained Refrigeration

By Components:

  • Evaporator
  • Compressor
    • Reciprocating
    • Hydrocarbon
    • Scroll
  • Condenser
  • Thermostat
  • Capillary tube

By Distribution Channel:

  • Offline Stores
    • Hypermarkets
    • Departmental Stores
    • Multi-brand Store s
    • Discount Stores
    • Specialty stores
  • Online Retail Stores

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Author:

Ronak Shah (Associate Vice President at Future Market Insights) is deeply committed to uncovering actionable insights for consumer and food and beverage players. She brings a unique blend of analysis, industry trends, and consumer behavior to put data into perspective.

What she makes out of data becomes a delight to read. She has authored many opinions, including for publications like Process Industry Informer and Spinal Surgery News, as she understands the market pulse and consumers’ shifting preferences.

She likes to bring experts to a roundtable to weigh the impact of a trend on an industry. Catch up with her discussion on the impact of AI in packaging.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

High Content Screening Market to Reach USD 3 Billion in 2022 at a 5.8% of CAGR

High Content Screening
High Content Screening Market

The global market for high content screening (HCS) market is poised for substantial growth, with an anticipated valuation reaching USD 1.6 billion in 2022 and projected to expand at a promising compound annual growth rate (CAGR) of 5.8%. This growth trajectory underscores the increasing adoption of HCS technologies in drug discovery, biological research, and pharmaceutical development.

High content screening, also known as cellomics, utilizes advanced imaging and analysis techniques to accelerate drug discovery processes and enhance biological research capabilities. These systems leverage digital microscopy, flow cytometry, and sophisticated IT platforms for comprehensive analysis and data storage, providing invaluable insights into cellular functions and drug interactions.

Leading companies in the industry are concentrating on technology advancements to raise the precision and effectiveness of high content screening systems as the market grows. This rising trajectory highlights how important HCS is to the advancement of medicinal advances and medical research.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-426

Finding and developing new drugs involves the use of high content screening. The increasing amount of research being done on target identification and validation, along with the ongoing quest for new drug candidates, is predicted to drive an acceleration in the adoption of high content screening over the next few years. Furthermore, it is projected that demand will rise over the course of the projection period as a result of a continued emphasis on manufacturing high-quality and technologically advanced cell imaging systems.

Nevertheless, the COVID-19 pandemic significantly impeded investigations and advancements. The market is anticipated to suffer as a result of this. However, it is anticipated that the market will grow in the upcoming years due to a rise in the amount of money major manufacturers are investing in the creation of cutting-edge cell imaging products.

Key Takeaways

  • The CAGR for the global market over the preceding period was 5.1%.
  • Over the coming decades, the market in India is anticipated to grow at a CAGR of 6.6%.
  • With more than 7.3% of all demand recorded in Europe in 2022, Germany has emerged as a major market.
  • Over the coming decade, the market in China is anticipated to grow at a CAGR of 7.8%.
  • The highest demand for High Content Screenings came from the pharmaceutical and healthcare industries.

“The rising prevalence of multiple infectious diseases with a variety of symptoms raises the demand for innovative treatments. As a result, there will be an increase in biotechnology and pharmaceutical study and development efforts to identify new drug candidates. Imaging technologies are becoming increasingly important in drug discovery and analysis.” says an FMI analyst.

Competitive Landscape:

Key players in the HCS market employ strategies such as mergers and acquisitions, product launches, collaborations, and alliances to expand their businesses.

  • Particle Works, a progressive company that creates and markets cutting-edge particle engineering platforms, declared the release of the Automated Library Synthesis (ALiS) System, a new ground-breaking platform, in November 2022. This innovative platform favors automation in the early stages of the creation of drugs as well as high-throughput evaluation of lipid nanoparticle (LNP) formulations and mRNA candidates.
  • The Twist High Throughput Antibody Production platform, developed by California-based Twist Bioscience Corporation, was made public in April 2022. It allows customers to convert candidate genetic sequences into cleansed antibodies for use in a variety of applications related to screening and therapeutic discovery projects.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-426

Key Companies Profiled: 

  • Thermo Fisher Scientific Inc.
  • Becton Dickinson, and Company
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer Inc.
  • Sysmex Corporation
  • Merck KGaA
  • Danaher Corporation
  • Yokogawa Electric Corporation
  • BioTek Instruments Inc.

Key Segments Profiled in the High Content Screening Industry Survey:

Product Type:

  • Cell Imaging & Analysis
    • HCS Instruments
      • High-End HCS
      • Mid End HCS
      • Low-End HCS
    • Flow Cytometers
  • Consumables
    • Microplates
    • Reagents & Assay Kits
    • Other Consumables
  • Software
  • Services

Industry:

  • Pharmaceutical & Healthcare
  • Biotechnology
  • Educational Institutions
  • Independent CRO
  • Government Organizations
  • Others

Application:

  • Primary & Secondary Screening
  • Target Identification & Validation
  • Toxicity Studies
  • Compound Profiling
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Get Full Market Analysis Now: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/426

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Point-of-Care Breathalyzer Market Expected to Reach USD 658.9 Million by 2032 at a 5.5% of CAGR

Point-Of-Care Breathalyzer Market
Point-Of-Care Breathalyzer Market

The global market for point-of-care breathalyzers market is poised for significant growth, with anticipated demand reaching USD 385.7 million in 2022 and projected to expand at a steady compound annual growth rate (CAGR) of 5.5% to approximately USD 658.9 million by 2032. This growth trajectory underscores increasing awareness of alcohol-related risks and advancements in portable diagnostic technologies.

Point-of-care breathalyzers are portable devices used for immediate alcohol level testing, providing rapid results outside of traditional laboratory settings. The market’s expansion is driven by rising alcohol consumption globally, stringent road safety regulations, and growing demand for portable and user-friendly diagnostic tools.

Point-of-care breathalyzers play a crucial role in law enforcement, workplace safety, and personal use, providing immediate and accurate readings of blood alcohol content. As technology continues to advance, these devices are becoming more user-friendly and accessible, further fueling market growth.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2286

The word “Breathalyzer” has been used to refer to a variety of devices, including Alcotest, Alcosensor, Datamaster, Intoxilyzer, and Intoximeter, since 1954. The Breathalyzer device is made up of three parts: the breath sample system, the two chemical-containing glass tubes, and the photocells that are connected to the meter and show a color shift.

The Breathalyzer device employs a redox reaction to produce a color shift in dichromate ions that is exactly proportionate to the amount of alcohol in breath. The dichromate ion’s red-orange color changes to green.

Point-of-Care Breathalyzer Market: Drivers and Restraints

Point-of-care Breathalyzer market has seen enormous growth due to its significant use to maintain safety, order and discipline amongst population. The major drivers for point-of-care Breathalyzer market is alarming increase in alcohol consumption seen at all age groups and also increase in road accidents due to drink driving.

Due to strict government regulations, drink driving and alcohol abuse during work hours has led to increase in demand for modern use portable Breathalyzer. Use of personal portable Breathalyzer to check for alcohol content within normal limits to keep a check on safe driving and productive working hours has given a drive for point-of-care Breathalyzer market worldwide.

Moreover easy availability of personal Breathalyzer that can be ordered online according to ones choice, has also been a factor to drive point-of-care Breathalyzer market. Awareness initiative taken by government has also led to increase of market size for point-of-care Breathalyzer market.

High cost of Breathalyzer and less market for new brands producing Breathalyzer were seen to hamper in the past for but modern portable cheap Breathalyzer are taking over the point-of-care Breathalyzer market now.

Point-of-Care Breathalyzer Market: Overview

According to a study report published in South Africa about 10% of the country’s GDP is lost due to alcohol abuse annually which is equal to R240 billion. Also worldwide there is much loss due to alcohol abuse leading to immense destruction in drunk driving accidents, expensive alcohol abuse treatment and loss of manpower and productive working hours brings an overall effect on worldwide economy.

Thus awareness due to such losses have led government to take strict measures in field of law enforcement and highway safety administration to bring down losses. Efficient use of point-of-care Breathalyzer to prevent such loss has proved beneficial and made people aware of its legal consequences being the reason for increasing market for of point-of-care Breathalyzer market.

Mandatory alcohol test are carried out worldwide in workplaces such as transport, construction sites mining, shipping, airlines, defense centres, rehabilitation centres to maintain safety of individuals increasing market size for point-of-care Breathalyzer market over globe.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-2286

Point-of-Care Breathalyzer Market: Key Players

Some of the key players in point-of-care Breathalyzer market include Drägerwerk AG & Co. KGaA, Intoximeters,Lion Laboratories Limited, Lifeloc Technologies, Inc., Inc., , BACtrack, Quest Products, Inc., Alere, Inc., and C4 Development, Andatech Private Limited Ltd. Most of the providers of point-of-care breathalyzer are adopting the strategy of providing these products through e-commerce, so that buyers can browse the products according to their needs.

Based on product type, the point-of-care breathalyzer market is segmented into the following:

  • Desktop Point-of-Care Breathalyzer
  • Portable Point-of-Care Breathalyzer
  • Handheld Point-of-Care Breathalyzer

 Based on product technology, the point-of-care breathalyzer market is segmented into the following:

  • Chemical reaction (Breathalyzer).
  • Fuel-cell technology (Alcosensor III or IV).
  • Infrared Spectroscopy (Intoxilyzer).

Based on end user, the point-of-care breathalyzer market is segmented into the following:

  • International and National transport systems.
  • Rehabilitation centres.
  • Government and private offices.
  • Diagnostic centers.
  • Home care settings

In-Depth Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/2286

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Diagnostic X-ray System Market Expected to Reach USD 20.46 Billion by 2032 at a 6.1% of CAGR

Global Diagnostic X-Ray System Market
Global Diagnostic X-Ray System Market

The global market for diagnostic x-ray systems market is set for substantial growth, projected to achieve a valuation of USD 11.30 billion by the end of 2022 and expand at a robust compound annual growth rate (CAGR) of 6.1% to approximately USD 20.46 billion by 2032. This growth trajectory underscores increasing healthcare demands, technological innovations, and the pivotal role of diagnostic imaging in medical diagnostics.

Diagnostic x-ray systems utilize electromagnetic radiation to create images of internal body structures, aiding in the detection and diagnosis of medical conditions across various medical specialties. The market’s expansion is driven by advancements in digital radiography, fluoroscopy, and portable x-ray systems, enhancing imaging quality and patient care outcomes.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-667

In the ten years since the introduction of medical equipment with artificial intelligence and Internet of Things integration, the healthcare sector has grown significantly. Technology development has greatly expanded the possibilities for medical diagnosis and therapy.

The analysis provides substantial data sets that validate important trends propelling the market growth for diagnostic x-ray systems. It provides information on the tactics used by the top businesses to identify and resolve issues that are predicted to impede the market’s expansion for diagnostic x-ray systems. Our thorough examination and understanding of the historical, present, and projected market conditions enable the Diagnostic X-Ray System market study to assist in identifying the issues and providing solutions that will ensure the success of small and medium-sized businesses.

Key highlights of the comprehensive analysis on the Diagnostic X-Ray System market include:

  • Market Size and Growth Trends: Projections indicate robust growth in the Diagnostic X-Ray System market, with a CAGR of 6.1% and predicted values reaching US$ 20.46 billion by 2032.
  • Dominance of Medical X-Ray Devices: Medical x-ray devices are expected to maintain the largest market share in 2021, underscoring their significance in diagnostic imaging procedures.
  • Technological Advancements: Ongoing advancements in medical imaging technology, including digital radiography and computed tomography (CT), are driving innovation and enhancing the diagnostic capabilities of x-ray systems.
  • Global Market Dynamics: The analysis provides insights into market dynamics, including drivers, restraints, opportunities, and challenges shaping the growth trajectory of the Diagnostic X-Ray System market across different regions.

Competitive Landscape:

The market for diagnostic X-Ray systems is highly fragmented. Increased application in the field of healthcare, as well as security purposes, has led many companies to enter the market by way of providing services or acquiring smaller companies offering these services in order to maintain as well as grow their current market position.

  • In August 2022, Thermo Fisher Scientific Inc. partnered with Structura Biotechnology Inc., in order to develop a single particle analysis software solution, which will integrate Thermo Fisher’s Smart EPU software with a cryo-transmission electron microscope (cryo-TEM) technology.
  • In March 2022, Canon Medical Systems Corporation acquired Nordisk Rntgen Teknik A/S, a Danish firm to develop a cutting-edge technology to produce and manufacture screening X-ray systems

Similarly, recent developments related to companies manufacturing diagnostic x-ray systems have been tracked by the team at Future Market Insights, which are available in the full report.

Diagnostic X-Ray System Market: Segmentation

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Detailed analysis on the geographical region and country wise insights are offered in the latest Diagnostic X-Ray System market report with established market players as well as incumbents in the region.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-667

Key Market Segments Covered in Diagnostic X-Ray System Industry Research

By Product:

  • Medical X-ray Devices
    • Fixed/floor mounted
    • Mobile and Portable Devices
  • X-Ray Diffraction (XRD)
    • Powder Diffraction
    • High-Resolution XRD
    • Custom XRD
  • Security X-Ray Devices
    • Closed X-Ray Systems
    • Full body scanner
      • Single View
      • Dual View
  • X-Ray Fluorescence (XRF)
  • SAXS/WAXS

By Application:

  • Medical
  • Research and Development
  • Security

By End User:

  • Hospital
  • Diagnostic Imaging Centers
  • Airports
  • Malls
  • Railway & Metro Stations
  • Government Facilities & Homeland Security

Comprehensive analysis of the regional markets offers exclusive insights on the market performance across geographies along with relevant graphs, figures, and list of tables.

Competitive Analysis

By Prominent Market Players

  • Shimadzu Corporation
  • Medlink Imaging, LLC
  • Konica Minolta Healthcare Americas, Inc.
  • Leidos
  • ODSecurity
  • Rigaku Corporation
  • Anton Paar GmbH
  • Braun & Co. Limited
  • Xenoc
  • Proto Manufacturing
  • OSI Systems
  • Siemens Healthineers
  • General Electric Company
  • FUJIFILM Holdings Corp
  • Koninklijke Philips N.V.
  • Carestream Health
  • Canon Medical Systems Corporation
  • Smiths Detection Group Ltd
  • Thermo Fisher Scientific Inc.
  • Astrophysics Inc.
  • Malvern Panalytical Ltd
  • NUCTECH COMPANY LTD
  • Bruker

Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/667

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Liver Transplant Market Projected to Reach USD 2,653.4 Million by 2033 at a 6.5% of CAGR

Global Liver Transplantation Market
Global Liver Transplantation Market

The global market for liver transplants market is poised for significant growth, with a current market value expected to reach USD 1,409.8 million and projected to expand to approximately USD 2,653.4 million by 2033. This growth trajectory reflects a steady compound annual growth rate (CAGR) of 6.5% during the forecast period, driven by rising awareness of liver health and advancements in transplant technologies.

Liver transplants involve the surgical replacement of a diseased or failing liver with a healthy liver from a donor. The market’s expansion is fueled by increasing prevalence of liver diseases, including cirrhosis and liver cancer, and advancements in surgical techniques and immunosuppressive therapies enhancing transplant success rates.

Better surgical results and cutting-edge medical technologies are also fueling the market’s expansion, guaranteeing better patient care and long-term health advantages. The market for liver transplants is anticipated to have a substantial impact on healthcare, offering therapies that can save lives and improving the quality of life for a great number of people.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1281

The market for liver transplants is expected to develop in the near future, with improvements in treatment techniques expected to contribute significantly to this growth. The government’s and some private healthcare facilities’ reimbursement policies have led to an increase in the market for liver transplants.

Weforum (2022) reports that over 130,000 organ transplants were completed in 2020. The liver and heart were the next most common organs, after the kidney. A small number of companies that manufacture surgical instruments and preservation techniques control the majority of the liver transplant market.

For example, a group of Swiss doctors came up with a novel way in June 2022 to shorten the waiting list for organ transplants. In addition, the surgeons created a novel technique to sustain a damaged liver for a few days. In order to see encouraging progress, the staff is still keeping an eye on the patient.

The transplant waiting list may be shortened by developing new methods for storing injured livers as well as conducting efficient stem cell, tissue engineering, and organogenesis research and development.

Key Takeaways :

  • The North American region showed a 29.2% share of the liver transplantation market.
  • European nations also show promising market demand in the liver transplantation market, with a share of 20.7%.
  • Based on treatment type, liver transplantation surgery dominates the liver transplantation market with a 61.1% global revenue share.
  • According to the forecast, 51% of liver transplantation surgeries are done in hospitals, while the rest are done in ambulatory and adult liver transplantation centers.

Recent Developments Detected by FMI in the Liver Transplantation Market:

  • In 2022, Jaslok Hospital and Research Center in Mumbai saved two lives with a single liver transplantation surgery. This transplantation surgery, also known as split cadaver liver donation surgery, is where the liver is split into two. It was then used by both an adult and a pediatric recipient simultaneously.
  • In August 2022, Integrated Graphene, with a team of scientists, developed an electrochemical biosensor to detect biliary complications in donor livers. The device, Gii-Sens, can detect the quality of the liver before transplantation. It can prevent the development of biliary complications and match the donor-recipient for transplant. According to the makers of Gii-Sens, the device is portable, economical, and responds fast to point-of-care diagnostics.

Key Players:

  • Allosource
  • Conatus Pharmaceuticals Inc.
  • Digna Biotech S.L.
  • Dompe Farmaceutici S.p.A.
  • Isogenis, Inc.
  • RedHill Biopharma Ltd.
  • Thompson Surgical
  • Integra Life Sciences
  • Baxter International Inc.
  • XVIVO
  • VirTech Bio
  • Vital Therapies
  • HepaTx
  • Humedics

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-1281

Key Segments Profiled in the Global Liver Transplantation Market:

By Treatment Type:

  • Liver Transplantation Surgery
  • Post-Surgery Anti-Rejection Treatment
  • Cyclosporine
  • Tacrolimus
  • Sirolimus Prednisone Azathioprine
  • Mycophenolate Mofetil

By End Use:

  • Hospitals
  • Adult Liver Transplantation Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/1281

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Periodontal Market Projected to Reach USD 24.4 Billion by 2032 at a 10.4% of CAGR

Periodontal Market
Periodontal Market

The global periodontal market is poised for substantial growth, with an anticipated valuation of USD 9.1 billion in 2022, projected to expand at a robust compound annual growth rate (CAGR) of 10.4% to reach approximately USD 24.4 billion by 2032. This growth trajectory underscores rising awareness of dental health and advancements in periodontal treatment technologies worldwide.

Periodontal diseases affect the tissues surrounding and supporting the teeth, including gums and bones. The market’s expansion is driven by increasing prevalence of periodontal disorders, aging population prone to dental issues, and advancements in dental devices and treatments aimed at improving oral hygiene and treatment outcomes.

The market is growing quickly because to the rise in periodontal disorders and increased awareness of oral health. This growth is being driven by advancements in periodontal devices and treatments, as medical professionals aim to provide better care and more effective solutions for gum health.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15640

The American Academy of Periodontology states that the main risk factors for the development or worsening of periodontal or gum diseases are aging, smoking or tobacco use, genetic factors, stress, some medications (like oral contraceptives and antidepressants), other systemic diseases, poor nutrition or obesity, and a host of other factors.

For Instance:

In August 2021, BIOLASE, Inc. announced a clinical advisory collaboration that will promote dental laser adoption and boost the hands-on training opportunities. This collaboration was announced with Dr. L. Stephen Buchanan, who is one of the top endodontists in the world.

Key Takeaways:

  • Device type dominated the market with 6% market share in the product segment of the global periodontal market in 2021.
  • Scaling and root planing procedures accounted for 1% of the global market share in 2021.
  • Dental clinics segment dominated the market in 2021 with a share of 4% of the end user category of the global periodontal market.
  • North America dominates among the seven regions, with a market share of 4% in 2021.

“Increasing prevalence of the gum diseases and the advancements in terms of the technology used in diagnostic instruments is set to propel the sales of the periodontal market across the globe,” says an analyst of Future Market Insights.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15640

Market Competition

The periodontal market is highly fragmented because of the large number of players in the market both local and international. There is a broad range of products that can be categorized under the periodontal market, making it a broad market. The strategies that are majorly followed by the key players of the periodontal market include product launches and expansions.

  • In June 2018, LM-Instruments Oy, a subsidiary of Planmeca Oy, introduced ten new products to its LM Sharp Diamond hand instruments portfolio. It includes a sickle scaler called LM-SharpJack.
  • In May 2021, Sandoz, a subsidiary of Novartis AG, announced the expansion of its production capabilities in Europe to strengthen European antibiotic manufacturing.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the periodontal market in its latest study, presenting a historical demand assessment of 2015 – 2021 and projections for 2022 – 2032.

The research study is based on the product– (device type (diagnostic instruments (probes (single-sided probes and double-sided probes), mouth mirrors and explorers), treatment instruments (scalers & curettes, custom-fit trays, cleansing & polishing instruments, periodontal endoscopes, dental lasers and dental implants (endosteal implants and subperiosteal implants)) and surgical instruments) and drug type (systemic antibiotics and local antibiotics)), by procedures (scaling and root planing, gum grafting, regenerative therapy, dental crown lengthening, periodontal pocket procedures, single tooth dental implants and multiple tooth dental implants), by end user (hospitals, dental clinics, group dental practice and ambulatory surgical centers) across seven key regions of the world.

Key Market Segments Covered in Periodontal Industry Research

By Product:

  • Device Type
    • Diagnostic Instruments
      • Probes
        • Single Sided Probes
        • Double Sided Probes
      • Mouth Mirrors
      • Explorers
    • Treatment Instruments
      • Scalers & Curettes
      • Custom-Fit Trays
      • Cleansing & Polishing Instruments
      • Periodontal Endoscopes
      • Dental Lasers
      • Dental Implants
        • Endosteal Implants
        • Subperiosteal Implants
    • Surgical Instruments
  • Drug Type
    • Systemic Antibiotics
    • Local Antibiotics

By Procedures:

  • Scaling And Root Planing
  • Gum Grafting
  • Regenerative Therapy
  • Dental Crown Lengthening
  • Periodontal Pocket Procedures
  • Single Tooth Dental Implants
  • Multiple Tooth Dental Implants

By End User:

  • Hospitals
  • Dental Clinics
  • Group Dental Practice
  • Ambulatory Surgical Centers

In-Depth Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15640

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Dental Fluoride Varnish Market Projected to Reach USD 229.3 Million by 2032 at a 3.9% of CAGR

Dental Fluoride Varnish Market
Dental Fluoride Varnish Market

The global market for dental fluoride varnish market is poised for steady growth, with a projected valuation of USD 156.5 million by the end of 2022 and expected to expand at a compound annual growth rate (CAGR) of 3.9% to reach USD 229.3 million by 2032. This growth trajectory highlights increasing emphasis on preventive dental care and rising awareness of oral health benefits worldwide.

Dental fluoride varnish is a topical dental treatment applied to teeth to prevent cavities and strengthen enamel. The market’s expansion is driven by growing oral healthcare awareness, advancements in dental technologies, and the adoption of preventive dental care practices among both children and adults.

The market is expanding due to growing investments in dental care advancements as well as increased awareness of oral health. Dental fluoride varnishes are essential for preventative dentistry because they provide a strong defense against dental decay and aid in maintaining good oral hygiene.

“Our research indicates that the dental fluoride varnish market is set for substantial growth over the next decade,” stated our lead market analyst. “The dominance of resin-based varnishes highlights the preference for high-quality, effective dental products among consumers and healthcare providers alike.”

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15641

As more information becomes available, the use of fluoride varnishes as a potent dental disease preventive technique will progressively acquire acceptance. The dental fluoride varnish market is expected to be driven in the upcoming years by the fact that fluoride varnish is also inexpensive, easy to apply, and generally safe to use in the mouth.

As a result, the market for dental fluoride varnish will expand overall in the upcoming years as more people use fluoride varnish.

Key Takeaways from Market Study

  • Resin Based Varnish are the leading in the segment by product, and hold approximately 68.4%market value share in 2021, owed to their advantage of preventing tooth decay and demineralization of the teeth.
  • Children lead the dental fluoride varnish market within the age group segment with the market share of nearly 39.85 in 2021 in the global market, as they are more prone to tooth decay and caries because of irregular eating habits and more consumption of sweet food.
  • Europe is considered the leading region with a global market share of around 31.6% in 2021, owed to more prevalence of dental fluorosis and tooth decay among the population.
  • The South Asian market for dental fluoride varnish is set to project a CAGR growth of 4.5%over the forecasted years, due to more population is prone to be affected by dental caries. In Southern Asia, the frequency of childhood caries ranged from 38 to 73.7%.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15641

Market Competition

Key players employ several developmental strategies like collaborations and product launches to provide a comprehensive range of products to its consumers.

  • In January 2021, Cantel Medical Corp. and STERIS plc announced that STERIS had signed a binding contract to buy Cantel through a U.S. subsidiary. Cantel is a multinational company that primarily serves endoscopic and dentistry customers with equipment and services for infection prevention.
  • In May 2021, It was revealed that Colgate-Palmolive Company and 3Shape were working together to bring the Colgate Illuminator, an innovative teeth-whitening equipment customized for each patient, to dentist offices all throughout the United States. The new technology will make consultations more accurate and provide a better patient experience.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the dental fluoride varnish devices in its latest study, presenting a historical demand assessment of 2015 – 2021 and projections for 2022 to 2032. The global dental fluoride varnish market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.

Key Market Segments Covered in Dental Fluoride Varnish Industry Research

By Varnish:

  • Resin-Based Varnish
  • Polyurethane-Based Varnish

By Age Group:

  • Children
  • Adolescents
  • Adults

By Application:

  • Dental Caries
  • White Spot Lesions
  • Dental Hypersensitivity

By Distributional Channel:

  • Dental Clinics
  • Hospitals
  • Retail Pharmacies & Drug Stores
  • Online Sales

Secure Your Market Analysis Now: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15641

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Halal Nutraceuticals and Vaccines Market Set to Reach USD 137,390.9 Million by 2033 at a 7.6% of CAGR

Halal Nutraceuticals and Vaccines Market
Halal Nutraceuticals and Vaccines Market

The global market for halal nutraceuticals and vaccines market is poised for substantial growth, with sales estimated to reach USD 137,390.9 million by 2033, up from USD 66,266.9 million in 2023. This growth trajectory reflects a steady compound annual growth rate (CAGR) of 7.6% over the forecast period, driven by rising consumer awareness, regulatory compliance, and the expanding Muslim population.

Halal nutraceuticals and vaccines adhere to Islamic dietary laws and regulations, ensuring products are permissible for consumption and use according to religious guidelines. The market’s expansion is propelled by increasing health consciousness, dietary preferences, and the integration of halal standards into global supply chains.

“Our analysis suggests that the halal nutraceuticals and vaccines market is entering a robust growth phase,” stated our lead industry analyst. “As consumer preferences shift towards halal-certified health products, manufacturers and suppliers have a significant opportunity to expand their market presence and meet this growing demand.”

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2703

The market for halal nutraceuticals and vaccines, which serves a global Muslim population that follows Islamic dietary regulations for both food and medicine, is at a pivotal nexus between dietary wellness and healthcare ethics. The market has experienced notable expansion due to the rising need for items that conform to the principles of Halal. Consumers can obtain functional meals, beverages, and supplements that adhere to Halal standards through the use of Halal nutraceuticals, guaranteeing that these products satisfy religious dietary restrictions.

A vital domestic good that has influenced practically every aspect of society is halal nutraceuticals and vaccines, which has created a strong and expanding global market for these products. The growing Muslim population in nations like Indonesia, Malaysia, Singapore, and other Asia Pacific countries (apart from Japan) is causing manufacturers to quickly enter various additional markets.

Over the projection period, APEJ’s booming halal-certified product demand is expected to support the industry, with an excellent market index of more than 6.2. Middle East & Africa (MEA) and Asia-Pacific (APEJ) are expected to contribute for more than 80% of the global market revenue for halal nutraceuticals and vaccines. Positive government efforts and actions to promote halal products are also expected to have a positive impact on the world market. Over the upcoming years, growth prospects should continue to be favorable due to the growing demand for halal dietary supplements. Both retail and hospital pharmacies will see strong demand.

Halal nutraceuticals and vaccines are pivotal in addressing diverse healthcare needs while adhering to Islamic dietary and ethical principles. These products cater to a global audience, combining the benefits of modern science and technology with compliance with Halal requirements, contributing to advancing healthcare accessibility and inclusivity. – Annalise by the Lead Research Analyst, FMI

Key Takeaways:

  • Government initiatives all over the world are expected to act favorably for the global halal nutraceuticals & vaccines market as it promote the consumption of halal products, resulting in higher demands. Furthermore, increasing demand from the Muslim population will spur the demand for halal dietary supplements.
  • According to the world and population trends, it has been predicted that by 2023, the world’s Muslim population will reach over 2.2 billion people across the globe. With growing awareness about halal ingredients and lifestyle disorders’ prevalence, people opt for halal dietary supplements such as general well-being, weight loss, and others.
  • Surging initiatives from governments of countries with vast Muslim populations are significantly encouraging investments in the production of halal products, which will improve growth. Furthermore, adopting uniform certification for halal products & increasing funds across Malaysia, India, Singapore, and other Asia Pacific excluding Japan (APEJ) countries will accelerate the growth over the forecast period.
  • The Malaysian government, which falls under the association of the Ministry of International Trade & Industry, developed halal products & services to promote halal products and make the country a halal hub. These initiatives are anticipated to boost market growth and provide lucrative revenue for the market players, specifically across APEJ and MEA.

Competitive Landscape:

Manufacturers are rapidly adopting various marketing strategies including new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base.

Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-2703

Key Players:

  • Abbott Laboratories
  • Nestlé
  • Amway
  • Herbalife International of America, Inc.
  • AJ Biologics Sdn Bhd.
  • Agropur, Inc.

Halal Nutraceuticals and Vaccines Market Segmentation:

By Product Type:

  • Halal Dietary Supplements
  • Halal Vaccines

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Super Markets

By Application:

  • Sports Nutrition
  • General Well-being
  • Immune & Digestive Health
  • Bone & Joint Health
  • Heart Health
  • Disease Prevention
  • Weight Loss

By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific Excluding Japan
  • Japan
  • The Middle East and Africa (MEA)

In-Depth Market Insights Now: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/2703

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Liquid Biopsy Market Projected to Reach USD 10,938.6 Million by 2033 at a 21.7% of CAGR

Liquid Biopsy
Liquid Biopsy Market

The global liquid biopsy market is poised for significant growth, with estimates suggesting a revenue of USD 1,538.3 million in 2023 and projected to reach USD 10,938.6 million by 2033. This growth trajectory reflects a robust compound annual growth rate (CAGR) of 21.7% during the forecast period, driven by increasing adoption of non-invasive diagnostic techniques and advancements in cancer screening technologies.

Liquid biopsy involves the analysis of biomarkers, such as circulating tumor cells (CTCs) and cell-free DNA (cfDNA), extracted from blood or other bodily fluids to detect and monitor various diseases, primarily cancer. The market’s expansion is propelled by its ability to provide early and accurate diagnosis, monitor treatment response, and facilitate personalized medicine approaches.

The market for liquid biopsies is growing at a rapid pace due to several factors, including the rising incidence of cancer, the development of genetic technologies, and the rising need for less invasive diagnostic techniques. Liquid biopsies have the potential to change the field of disease identification and management, and this is a realization that both patients and healthcare providers are beginning to see.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1396

Liquid biopsies have become more common in recent years due to the desire for more personalized treatment options. Since liquid biopsy is widely available and reasonably priced in many labs, particularly in developing countries, its use is growing in popularity. For instance, several labs offer liquid biopsy tests.

“Key players are bringing cost reductions in liquid biopsy tests and partnering with local product distributors to strengthen their network base in target markets. Currently, a trend toward emerging economies has been spotted, as cancer cases are particularly on the rise, and a large population base provides significant opportunities in these markets,” says an FMI analyst.

Key Takeaways from the Liquid Biopsy Market Report

  • The North America liquid biopsy market is expected to account for a leading share of 50.84%. The United States is predicted to account for 43.8%, enjoying a dominant share in the global and regional markets.
  • The Europe market is anticipated to acquire a market share of 19.6% in 2023. Germany holds a prominent share in the region. In 2023, the country is predicted to amass a total of 6.6% share in the global market.
  • In Europe, the United Kingdom is predicted to expand at a robust CAGR of 26.4% through 2033.
  • In Asia Pacific, China and India display a remarkable percentage of growth, i.e., 29.7% and 24.4%, respectively, through 2033.
  • CTC (Circulating Tumor Cells) is projected to obtain a significant market share of 56.9% by biomarker type in 2023.
  • By sample type, blood sample type holds prominence in the liquid biopsy market.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-1396

Key Developments by Liquid Biopsy Market Players

  • QIAGEN N.V. (the Netherlands), in May 2022, introduced a therascreen EGFR Plus RGQ PCR Kit, which is a new in vitro diagnostic test for the analysis of sensitive EGFR mutation.
  • Guardant Health, Inc., in June 2021, introduced Guardant360 Response test that finds variations in circulating tumor DNA (ctDNA) levels.
  • Hoffmann-La Roche Ltd. (Switzerland), in October 2020, gained United States FDA approval for the extended claims for cobas EGFR Mutation Test v2 to be deployed as a companion diagnostic for an extensive range of therapies to manage non-small cell lung cancer (NSCLC).
  • Biocept, Inc., in March 2020, agreed with a California-based Independent Physician Association (IPA) to offer its Target Selector liquid assay services to patients and physicians in the network.

Key Companies Profiled:

  • BIOCEPT, INC.
  • Qiagen N.V.
  • Trovagene, Inc
  • Janssen Global Services, LLC
  • MDxHealth SA
  • Natera, Inc
  • F. Hoffmann-La Roche Ltd
  • Silicon Biosystems
  • Pathway Genomics Corporation
  • Sysmex Corporation
  • Others

Key Segments Profiled in the Liquid Biopsy Industry Survey:

By Biomarker Type:

  • CTCs (Circulating Tumour Cells)
  • ctNA (Circulating tumor Nucleic Acids)
  • Exosomes

By Sample Type:

  • Blood Liquid Biopsy
  • Urine Liquid Biopsy
  • Other (Plasma, Saliva, CSF) Liquid Biopsy

By Application Type:

  • Liquid Biopsy for Lung Cancer
  • Liquid Biopsy for Gastrointestinal Cancer
  • Liquid Biopsy for Prostate Cancer
  • Liquid Biopsy for Breast Cancer
  • Liquid Biopsy for Colorectal Cancer
  • Liquid Biopsy for Leukemia

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

Obtain In-Depth Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/1396

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Digital Pathology Market Set to Reach USD 24,961.8 Million by 2033 at a 13.5% of CAGR

Digital Pathology
Digital Pathology Market

The global digital pathology market is poised for significant growth, projected to achieve a sizeable valuation of USD 7,035.8 million in 2023 and surge to USD 24,961.8 million by 2033. This growth trajectory represents a robust compound annual growth rate (CAGR) of 13.5% during the forecast period from 2023 to 2033, underpinned by technological advancements and increasing adoption of digital solutions in healthcare.

Digital pathology involves the digitization of pathology slides and images, enabling remote viewing, analysis, and sharing of pathology data for enhanced diagnostic accuracy and efficiency. The market’s expansion is driven by the growing demand for efficient diagnostic techniques, improved workflow management, and the integration of artificial intelligence (AI) for pathology analysis.

The market’s rapid expansion is driven by increasing adoption of digital pathology solutions in clinical and research settings, advancements in imaging technologies, and the growing demand for telepathology services. As healthcare providers and laboratories continue to embrace digital transformation, the digital pathology market is set to play a pivotal role in advancing patient care and medical research.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-124

The digital pathology market is set to redefine the future of diagnostics, offering unparalleled benefits in terms of speed, accuracy, and accessibility. As healthcare providers increasingly turn to digital solutions to enhance diagnostic capabilities, the market is poised for substantial growth. This evolution in pathology not only streamlines the diagnostic process but also ensures better patient outcomes through early and precise detection of diseases.

Medical professionals, industry stakeholders, and investors are invited to explore the vast opportunities within the digital pathology market. The next decade promises significant advancements and growth, positioning digital pathology as a cornerstone of modern medical diagnostics.

Surge in R&D in Digital Pathology to Augment Sales in Forthcoming Years

In recent years, the digital pathology industry has increased investments in biosimilar research and development initiatives, primarily for cancer treatment and Covid-19 treatment, which have substantially fuelled the market expansion.

Contract Research Organizations (CROs), in-vitro diagnostics (IVD) laboratories, clinical laboratories, and regulatory consultants are being assigned biosimilar development responsibilities by pharmaceutical corporations. These enterprises are developing in order to provide more cost-efficient solutions to their customers, requiring the use of digital pathology instruments to diagnose, research, and design effective healthcare solutions.

Cancer diagnostic Opens New Avenues for Digital Pathology Companies

Due to the sheer increasing occurrence of cancer, there is an increase in spending on digital pathology equipment. Complications arising from late cancer diagnosis, particularly in the case of blood cancer and lung cancer, necessitate the use of significant capital resources during therapy and diagnosis. The success of digital pathology in research is driving demand for these systems in the cancer research industry. This is also encouraging government investors to invest in digital pathology systems for clinical diagnosis. A significant amount of money is spent on cancer diagnosis and therapy monitoring. This explains why digital pathology solutions are in high demand.

Competitive Landscape

  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm
  • OptraSCAN, Inc.
  • Inspirata, Inc.
  • Sectra AB

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-124

Some of the recent developments in digital pathology market are as follows:

  • In May 2021, Leica Biosystems joined the European Society for Digital and Integrative Pathology (ESDIP) to assist pathology labs in developing laboratories in accordance with modern digital pathology instruments.
  • In March 2021, Roche inked a comprehensive merger agreement with GenMark Diagnostics to broaden its product and distribution channel for European consumers.

Key Segments:

Digital Pathology by Product Type:

  • Digital Pathology Equipment
  • Whole Slide Scanners
  • Brightfield Slide Scanners
  • Fluorescence Slide Scanners
  • Combination Slide Scanners
  • Clinical Microscope
  • Tissue Microarrays
  • Digital Pathology Software
  • Image Viewing and Analysis Software
  • On-premise
  • Cloud-based
  • Digital Pathology Information Systems
  • On-premise
  • Cloud-based
  • Digital Pathology Services
  • Installation and Integration Services
  • Consulting Services
  • Maintenance and Validation Services

Digital Pathology by Application:

  • Clinical Pathology
  • Molecular Diagnostics
  • Basic & Applied Research
  • Drug Development
  • Others

Digital Pathology by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

Get Full Market Analysis Now Purchase The Report With Your Work Email :
https://www.futuremarketinsights.com/checkout/124

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube